The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid escalating cyber threats facing the global healthcare sector, Abbott Laboratories has launched investigations into two cybersecurity incidents targeting legacy systems and its LabCentral customer portal. According to reports, the company asserted that business operations, product availability, and patient services remain unaffected by these events. The probe follows claims by hacking groups regarding data exfiltration from systems associated with the firm.
Healthcare companies are under increasing pressure to secure their infrastructure, as peers like UnitedHealth have faced similar breaches that weighed on sector sentiment. Abbott previously reported strong growth in its medical device segment during the last quarter, which may buffer the stock against negative sentiment if the breaches remain confined to non-core legacy systems. Per market data, maintaining operational continuity is a key factor for investor confidence during such security probes.
In the markets, ABT shares stood at $98.83 (close July 16, 2026), having traded between a day low of $94.99 and a high of $101.87. Investors are watching for official updates regarding the extent of the data involved, while the broader market monitors upcoming US economic catalysts, including the Consumer Price Index (CPI) release on July 14, which could influence healthcare stock valuations.